DNM1L and ovarian cancer: These important biomarkers have been identified in ovarian cancer, including superoxide dismutase 2 (SOD2) [103], Sab [104], cytoplasmic estrogen receptor β2 (cERβ2) [105], mimitin [106], TNF receptor-associated protein 1 (TRAP1) [107], mitochondrial ribosomal protein S12 (MRPS12) [108], MIEF2 [81], dynamin-related protein 1 (Drp1) [109], and calcium/calmodulin-dependent protein kinase I (CaMKI) [109].